Net shares · 365d
-79.7K
0 buy · 79.7K sell
Net value · 365d
-$2.6M
$0 in · $2.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
12
0 buy · 79.7K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$375.0K
9.0K sh · $41.67
Own -10%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$300.6K
9.0K sh · $33.40
Own -10%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$319.6K
9.0K sh · $35.51
Own -10%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$267.5K
9.0K sh · $29.72
Own -9%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$305.4K
9.0K sh · $33.93 avg · 2 lots
Own -13%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$150.0K
5.0K sh · $30.00
Own -7%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$112.0K
4.0K sh · $28.00
Own -6%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$112.4K
3.7K sh · $30.00
Own -5%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$117.2K
4.0K sh · $29.30
Own -6%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$273.4K
9.0K sh · $30.38
Own -11%
-
ALKS Sell·S
EVP R&D, Chief Medical Officer · 10b5-1
$283.8K
9.0K sh · $31.53
Own -11%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | ALKS | Sell S | 9.0K | $375.0K |
| May 1, 2026 | ALKS | Sell S | 9.0K | $300.6K |
| Apr 1, 2026 | ALKS | Sell S | 9.0K | $319.6K |
| Mar 2, 2026 | ALKS | Sell S | 9.0K | $267.5K |
| Feb 2, 2026 | ALKS | Sell S | 9.0K2 lots | $305.4K |
| Jan 8, 2026 | ALKS | Sell S | 5.0K | $150.0K |
| Jan 2, 2026 | ALKS | Sell S | 4.0K | $112.0K |
| Dec 3, 2025 | ALKS | Sell S | 3.7K | $112.4K |
| Dec 1, 2025 | ALKS | Sell S | 4.0K | $117.2K |
| Nov 3, 2025 | ALKS | Sell S | 9.0K | $273.4K |
| Oct 15, 2025 | ALKS | Sell S | 9.0K | $283.8K |
Buy Sell Non-market (grant · exercise · gift)
About Hopkinson Craig C.
This profile aggregates every SEC Form 4 insider transaction reported by Hopkinson Craig C. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.